MR-005: A Novel, Music-based Gait Rehabilitation Device Delivering Individualized, Progressively Challenging and Autonomous Rhythmic Auditory Stimulation at Home to Adults with Parkinson’s Disease 1161

People with Parkinson disease (PwPD) experience significant challenges to their walking as the disease progresses, including but not limited to reduced walking capacity, reduced clinically-relevant walking activity, and worsening gait quality, all of which are known to correlate with fall risk. 

Rhythmic auditory stimulation (RAS) is an intervention that leverages an external rhythmic stimulus, like music or a metronome, to improve aspects of walking in people with neurologic disease and injury (Thaut, 2015). Although RAS has been well demonstrated to improve gait for PwPD in the research literature, there are various factors that have limited its adoption and created variability in implementation. For example, barriers to implementation may include a high burden on patients by requiring in-clinic visits, a high burden on clinicians by requiring constant monitoring and adjustment to the music or metronome during an RAS session, and the resources needed to deliver RAS in an individualized, progressively challenging, and engaging manner. MedRhythms has developed a platform that could potentially address some of these barriers.

In this presentation, the presenters will review two studies conducted with MR-005 (commercial name: MOVIVE).  MOVIVE is a prescription medical device that delivers individualized, progressive, and engaging rhythmic auditory stimulation autonomously in the home, to support gait rehabilitation in people living with Parkinson's disease.